This site uses cookies to help us manage and improve the website and to analyse how visitors use our site. By continuing to use the website, you are agreeing to our use of cookies. For further information about cookies, including about how to change your browser settings to no longer accept cookies, please view our Cookie Policy. CIick for more info.

The Binding Site

Sector:  Medical Diagnostics

Country: UK

Investment date: September 2011

Partners: Management, Nordic Capital


The Binding Site is a UK-based international diagnostics business specialising in the research, development and manufacture of innovative, high-quality tests used for the detection of certain cancers and other serious disorders. Originally formed from a spin-out from Birmingham University, the company has over 25 years experience in producing highly sensitive and highly specific tests. The Binding Site and its associated product names have achieved strong brand recognition with an excellent reputation for quality, reliability and service. The company operates from a research and manufacturing facility in the UK and markets its products to ~95 countries globally through local sales subsidiaries and a network of distributors.  The Binding Site is headquartered in Birmingham, UK.

Website: https://www.bindingsite.com